Prendergast GC - Search Results

1

Immune escape as a fundamental trait of cancer: focus on IDO.

Prendergast GC. Prendergast GC. Oncogene. 2008 Jun 26;27(28):3889-900. doi: 10.1038/onc.2008.35. Epub 2008 Mar 3. Oncogene. 2008. PMID: 18317452 Review.

2

Accumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancers.

Puccetti P, Fallarino F, Italiano A, Soubeyran I, MacGrogan G, Debled M, Velasco V, Bodet D, Eimer S, Veldhoen M, Prendergast GC, Platten M, Bessede A, Guillemin GJ. Puccetti P, et al. Among authors: prendergast gc. PLoS One. 2015 Apr 16;10(4):e0122046. doi: 10.1371/journal.pone.0122046. eCollection 2015. PLoS One. 2015. PMID: 25881064 Free PMC article.

3

A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation.

Chien J, Narita K, Rattan R, Giri S, Shridhar R, Staub J, Beleford D, Lai J, Roberts LR, Molina J, Kaufmann SH, Prendergast GC, Shridhar V. Chien J, et al. Among authors: prendergast gc. Oncogene. 2008 Dec 11;27(58):7223-34. doi: 10.1038/onc.2008.360. Epub 2008 Sep 22. Oncogene. 2008. PMID: 18806825 Free PMC article.

4

A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase.

Banerjee T, Duhadaway JB, Gaspari P, Sutanto-Ward E, Munn DH, Mellor AL, Malachowski WP, Prendergast GC, Muller AJ. Banerjee T, et al. Among authors: prendergast gc. Oncogene. 2008 May 1;27(20):2851-7. doi: 10.1038/sj.onc.1210939. Epub 2007 Nov 19. Oncogene. 2008. PMID: 18026137

5

Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases.

Prendergast GC, Chang MY, Mandik-Nayak L, Metz R, Muller AJ. Prendergast GC, et al. Curr Med Chem. 2011;18(15):2257-62. doi: 10.2174/092986711795656072. Curr Med Chem. 2011. PMID: 21517753 Free PMC article. Review.

6

RhoB facilitates c-Myc turnover by supporting efficient nuclear accumulation of GSK-3.

Huang M, Kamasani U, Prendergast GC. Huang M, et al. Among authors: prendergast gc. Oncogene. 2006 Mar 2;25(9):1281-9. doi: 10.1038/sj.onc.1209174. Oncogene. 2006. PMID: 16247449

7

RhoB in cancer suppression.

Huang M, Prendergast GC. Huang M, et al. Among authors: prendergast gc. Histol Histopathol. 2006 Feb;21(2):213-8. doi: 10.14670/HH-21.213. Histol Histopathol. 2006. PMID: 16329046 Review.

8

Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity.

Lebowitz PF, Davide JP, Prendergast GC. Lebowitz PF, et al. Among authors: prendergast gc. Mol Cell Biol. 1995 Dec;15(12):6613-22. doi: 10.1128/MCB.15.12.6613. Mol Cell Biol. 1995. PMID: 8524226 Free PMC article.

9

Posttranscriptional regulation of cellular gene expression by the c-myc oncogene.

Prendergast GC, Cole MD. Prendergast GC, et al. Mol Cell Biol. 1989 Jan;9(1):124-34. doi: 10.1128/mcb.9.1.124-134.1989. Mol Cell Biol. 1989. PMID: 2467185 Free PMC article.

10

A new bind for Myc.

Prendergast GC, Ziff EB. Prendergast GC, et al. Trends Genet. 1992 Mar;8(3):91-6. doi: 10.1016/0168-9525(92)90196-b. Trends Genet. 1992. PMID: 1579994 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results